More than 100 million people in Europe and beyond trust Zentiva’s medicines. We continue to expand into multiple new territories and enlarge our portfolio in key therapeutical areas, like cardiology and circulation, diabetes, oncology, respiratory, CNS (central nervous system) and consumer health.